PMS2P11
Putative postmeiotic segregation increased 2-like protein 11
Also known as: PM2PB_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for PMS2P11 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
270 residues, UniProt reviewed canonical sequence.
>Q13670|PMS2P11
1 MEKLSAASGY SDVTDSKAMG PLAVGCLTKC SHAFHLLCLL AMYCNGNKGP EHPNPGKPFT
61 ARGFPASATF QTTPGPQASR GFQNPETLAD IPASPQLLTD GHYMTLPVSP DQLPCDDPMA
121 GSGGAPVLRV GHDHGCHQQP RICNAPLPGP GPYRTEPAKA IKPIDRKSVH QICSGPVVLS
181 LSTAVKELVE NSLDAGATNI DLKLKDYGMD LIEVSGNGCG VEEENFEGLM MSPFLPATSR
241 RRLGLDWCLI TMGKSSRRPP TPTPEGPQSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PMS2P11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PMS2P11 as an antibody target. Whether an autoantibody or antibody against PMS2P11 could matter depends on whether native PMS2P11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PMS2P11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PMS2P11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...